ZHONGZHIPHARM released its interim results, with profit attributable to shareholders of 8.783 million yuan, a year-on-year decrease of 89.5%

Zhitong
2025.08.26 12:29
portai
I'm PortAI, I can summarize articles.

According to the Zhitong Finance APP, ZHONGZHIPHARM released its performance report for the six months ending June 30, 2025, with revenue of 880 million yuan (RMB, the same below), a year-on-year decrease of 19.1%; profit attributable to the parent company owners was 8.783 million yuan, a year-on-year decrease of 89.5%; basic earnings per share were 0.010 yuan

According to the Zhitong Finance APP, ZHONGZHIPHARM (03737) announced its performance for the six months ending June 30, 2025, with revenue of 880 million yuan (RMB, the same below), a year-on-year decrease of 19.1%; profit attributable to the parent company’s shareholders was 8.783 million yuan, a year-on-year decrease of 89.5%; basic earnings per share were 0.010 yuan

Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2025 Longbridge｜Disclaimer